MDNAF News and Press, Mandatum Pankki Oyj From 04/23/19

TORONTO , ON and HOUSTON, TX , April 23, 2019 /PRNewswire/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, is pleased to announce that executives from Medicenna, Dr. Fahar Merchant, Chairman...

TORONTO, ON and HOUSTON, TX / ACCESSWIRE / March 27, 2019 / Medicenna Therapeutics Corp. (''Medicenna'' or the ''Company'') (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company announced today that Dr. Fahar Merchant, Chairman, President and CEO is scheduled to present at this...

Medicenna Therapeutics ( OTCQB:MDNAF ): Q3 EPS of -C$0.07. Press release More news on: Medicenna Therapeutics Corp., Earnings news and commentary, Consumer stocks news, ,

TORONTO and HOUSTON, TX , Feb. 14, 2019  /PRNewswire/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, today reported financial results for the three and nine months ended December 31, 2018 . The f...

Medicenna Presents Promising Clinical Data from Phase 2b Recurrent Glioblastoma Trial of MDNA55 Canada NewsWire TORONTO and HOUSTON, TX, Feb. 7, 2019 Strong interim survival trend (15.2 vs 8.5 months) emerging in IL4R positive patients TORONTO and HOUSTON, TX ...

Medicenna Shows Promising Pre-Clinical Results in Solid Tumor Models with its IL-2 Superkine, MDNA109 Canada NewsWire TORONTO, Feb. 6, 2019 Magnified IL-2 affinity towards CD122 potently synergizes with checkpoint inhibitors TORONTO , Feb. 6, 2019 /CNW/ - Medicenna ...

Noteworthy events during the week of February 3 - 9 for healthcare investors. More news on: AVROBIO, Amicus Therapeutics, Inc., Protalix BioTherapeutics, Inc, Healthcare stocks news, , Read more ...

Medicenna to Host Virtual Roadshow Webinar Canada NewsWire TORONTO and HOUSTON, TX, Jan. 25, 2019 January 29 th , 2019 at 2:00 p.m. ET TORONTO and HOUSTON, TX, Jan. 25, 2019 /CNW/ - Medicenna Therapeutics Corp. (" Medicenna " or the " Company ") (TSX: MDN...

Preliminary Results on MDNA55 and MDNA109 to be Presented at the Immuno-Oncology 360° Conference Canada NewsWire TORONTO and HOUSTON, Jan. 24, 2019 TORONTO and HOUSTON , Jan. 24, 2019 /CNW/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; O...